Mitralign Inc., a cardiovascular device company, today reported on the successful use of its technology to perform a percutaneous repair on a patient with tricuspid regurgitation (TR).
Mitralign Inc., a cardiovascular device company, today reported on the successful use of its technology to perform a percutaneous repair on a patient with tricuspid regurgitation (TR).